Veradermics CEO Reid Alexander Waldman disposes of common shares worth $7.24 million

• Veradermics CEO Reid Alexander Waldman cut his stake to 170,824 shares in an Aug. 17 filing.
• Sales totaled 67,500 shares at weighted average prices of USD 106.72 to USD 111.28.
• He exercised stock options for 3,452 shares at USD 12.19 before the sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-057813), on August 18, 2026, and is solely responsible for the information contained therein.